Conference Coverage
-
Conference Coverage
Hippocampal abnormalities seen in epilepsy subtypes may be congenital
NEW ORLEANS – Imaging studies suggest that changes in hippocampal volume seen in these patients probably occur before birth and are not the result...
-
Conference Coverage
Stroke endovascular therapy: The more you do, the better you do
HONOLULU – Centers performing more endovascular thrombectomies produced better patient outcomes.
-
Conference Coverage
Stroke thrombolysis looks safe 31+ days after prior stroke
HONOLULU – Current guidelines contraindicate stroke thrombolysis within 90 days of a prior stroke. New findings suggest that’s 60 days too long....
-
Conference Coverage
Large survey reveals that few MS patients have long-term care insurance
DALLAS – The findings suggest that clinical care teams should initiate early discussions of possible long-term needs with their patients.
-
Conference Coverage
Ublituximab depletes B cells in phase 2 trial
DALLAS – The investigational therapy may allow for lower doses and shorter infusion times, compared with available anti-CD20 treatments.
-
Conference Coverage
Can technology automate assessments of patients with MS in the clinic?
DALLAS – An iPad-based series of neuroperformance tests and patient-reported outcomes may facilitate the clinical evaluation of patients with...
-
Conference Coverage
What happens when RRMS patients discontinue their DMT?
DALLAS – Stopping DMT at a younger age poses a significantly higher risk of inflammatory activity.
-
Conference Coverage
Migraine associated with more severe disability in patients with MS
DALLAS – “Traditional migraine risk factors such as obesity, anxiety, and depression were also overrepresented in our cohort” of patients with MS...
-
Conference Coverage
Glyceryl trinitrate does not improve outcomes of ischemic stroke
HONOLULU – Although treatment reduced blood pressure, it did not reduce disability at 90 days, compared with sham....
-
Conference Coverage
Evaluations for possible MS often turn up one of its many mimics
DALLAS – At two multiple sclerosis (MS) centers, 74% of patients referred for a possible diagnosis of MS did not have the disease.
-
Conference Coverage
Neurologists grappling with patients who embrace ‘stem cell tourism’
DALLAS – The unethical practice of offering unproven cellular preparations to patients is rising in multiple sclerosis.
-
Conference Coverage
Survey of MS patients reveals numerous pregnancy-related concerns
DALLAS – Of those who became pregnant following diagnosis, 20% reported postpartum depression or anxiety.
-
Conference Coverage
MI, strokes spike during 30 days after cancer diagnosis
HONOLULU – During the first 30 days after a cancer diagnosis, the incidence of an MI or stroke jumped nearly 500%.
-
Conference Coverage
Second-generation hydrogel surpasses platinum for brain aneurysm closure
HONOLULU – In a randomized trial, brain aneurysm embolization with next-generation hydrogel coil led to fewer recurrences than bare platinum wire...
-
Conference Coverage
Which comorbidities most diminish quality of life in patients with MS?
DALLAS – Systemic lupus erythematosus, depression, and hyperthyroidism may have large effects on health-related quality of life in patients with...
-
Conference Coverage
Injectable nimodipine does not improve outcomes of subarachnoid hemorrhage
HONOLULU – EG-1962 significantly reduces the rate of angiographic vasospasm, compared with the standard of care, but...
-
Conference Coverage
Endarterectomy and stenting have similar efficacy in carotid stenosis
HONOLULU – A pooled analysis of two large trials indicates that carotid stenting and carotid endarterectomy have...
-
Conference Coverage
Andexanet alfa effectively reverses factor Xa inhibition
HONOLULU – The drug establishes good or excellent hemostasis in 82% of patients with acute major bleeding associated...
-
Conference Coverage
Genetic signature helps identify those at risk of MS
DALLAS – “In this effort to redefine this disease and when it starts, these molecular and cellular studies are becoming very important.”
-
Conference Coverage
New data bolster latitude’s association with MS prevalence
DALLAS – After integrating data from 94 new studies, “the latitudinal gradient in MS prevalence ... significantly enhanced in magnitude,”...
Latest News
-
Latest News
Can higher MAP post cardiac arrest improve neurologic outcomes?
CHICAGO – A target mean arterial pressure higher than what the guidelines recommend appears safe but has mixed results for improving neurologic...
-
From the Journals
Study hints at lacosamide’s efficacy for small fiber neuropathy
First study of lacosamide for Nav1.7-related small fiber neuropathy shows promise.
-
Feature
Phase 3 studies of antiamyloid Alzheimer’s drug crenezumab stopped
The molecule will continue to be tested in a study of familial Alzheimer’s in Colombia.
-
From the Journals
Mild aerobic exercise speeds sports concussion recovery
Subsymptom levels of aerobic exercise shortened recovery time, compared with stretching, in adolescent athletes.
-
Latest News
MS prevalence estimates reach highest point to date
The prevalence of multiple sclerosis remains higher for women than for men.
-
From the Journals
Total plasma tau correlates with dementia onset, Alzheimer’s disease
-
From the Journals
‘Trigger zone’ resection ups seizure-free odds in temporal lobe epilepsy
The findings, if confirmed in prospective interventional trials, could have important implications for surgery and drug development.
Video
-
News
Minimally invasive ICH lysis safely helps when clot adequately shrinks
HONOLULU – The primary endpoint from the phase 3 MISTIE III trial was neutral, apparently because clot lysis often fell short.
Literature Review
-
Literature Review
Can intraputamenal infusions of GDNF treat Parkinson’s disease?
The investigational therapy, delivered through a skull-mounted port, was well tolerated in a randomized, controlled trial and open-label extension...